Form 4: Aspira Women's Health CEO Nicole Sandford Increases Stake in Company
SEC Form 4 Filing
Aspira Women's Health CEO Nicole Sandford recently purchased 9,493 shares of company stock at an average price of $2.42.
Summary
- On May 31, 2024, Nicole Sandford, CEO of Aspira Women's Health Inc., purchased 9,493 shares of the company's common stock.
- The shares were bought at a weighted average price of $2.42, with individual transactions ranging from $2.34 to $2.45 per share.
- Following this transaction, Sandford directly owns 70,596 shares of Aspira Women's Health Inc.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the CEO's stock purchase, which signals confidence. However, it's a single transaction and doesn't provide a comprehensive view of the company's overall health.
Positives
- The CEO's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider buying is often viewed as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's important to consider the overall context of the company's performance and industry trends.
Stakeholder Impact
- The CEO's stock purchase could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/31/2024 | Date of stock purchase transaction |
| 06/03/2024 | Date of Form 4 filing |
Keywords
Aspira Women's Health, AWH, Nicole Sandford, Stock Purchase, Form 4, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.